BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$74.76 USD
+0.09 (0.12%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $74.78 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 21 - 40 ( 188 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
4Q23 - A Conservative Looking Guide for 2024
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Implications of the Abcam Saga (Potential MA) for Bio-Techne
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
3Q23 - Improving China and Protein Sciences Increase LT Visibility
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
2023 Life Sciences & MedTech Investor Forum: Key Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
2023 KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Data Points Suggest Accelerating Growth Guidance Is Happening
Provider: KeyBanc Capital Markets
Analyst: Research Department